Calliditas Therapeutics AB (CALT)
Calliditas Therapeutics Market Cap: 591.19M for May 16, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 16, 2024 | 591.19M |
May 15, 2024 | 594.06M |
May 14, 2024 | 606.23M |
May 13, 2024 | 564.09M |
May 10, 2024 | 551.21M |
May 09, 2024 | 545.58M |
May 08, 2024 | 551.80M |
May 07, 2024 | 553.90M |
May 06, 2024 | 540.21M |
May 03, 2024 | 536.72M |
May 02, 2024 | 509.94M |
May 01, 2024 | 535.11M |
April 30, 2024 | 535.11M |
April 29, 2024 | 500.57M |
April 26, 2024 | 523.32M |
April 25, 2024 | 521.96M |
April 24, 2024 | 496.47M |
April 23, 2024 | 488.42M |
April 22, 2024 | 485.26M |
April 19, 2024 | 501.83M |
April 18, 2024 | 473.66M |
April 17, 2024 | 502.91M |
April 16, 2024 | 477.66M |
April 15, 2024 | 508.54M |
April 12, 2024 | 509.88M |
Date | Value |
---|---|
April 11, 2024 | 550.94M |
April 10, 2024 | 577.51M |
April 09, 2024 | 603.81M |
April 08, 2024 | 577.24M |
April 05, 2024 | 580.46M |
April 04, 2024 | 592.54M |
April 03, 2024 | 570.26M |
April 02, 2024 | 570.26M |
April 01, 2024 | 563.56M |
March 28, 2024 | 563.82M |
March 27, 2024 | 576.62M |
March 26, 2024 | 586.37M |
March 25, 2024 | 586.10M |
March 22, 2024 | 570.27M |
March 21, 2024 | 584.89M |
March 20, 2024 | 571.61M |
March 19, 2024 | 563.56M |
March 18, 2024 | 591.73M |
March 15, 2024 | 598.44M |
March 14, 2024 | 602.47M |
March 13, 2024 | 622.06M |
March 12, 2024 | 592.27M |
March 11, 2024 | 597.10M |
March 08, 2024 | 593.08M |
March 07, 2024 | 620.72M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
DBV Technologies SA | 113.68M |
Cellectis SA | 218.73M |
Adaptimmune Therapeutics PLC | 296.19M |
Akari Therapeutics PLC | 11.73M |
Biodexa Pharmaceuticals Plc | 5.437M |
Market Cap Related Metrics
PS Ratio | 4.35 |
Price to Book Value | 17.78 |
Price | 22.03 |
Earnings Yield | -4.46% |